How to compare U.S. pharmaceutical manufacturers

Pharmaceutical sourcing is a regulated-site decision. Compare dosage form, FDA registration, quality-system scope, and batch documentation before comparing capacity or price.

Clusters this page covers

  • New Jersey and Pennsylvania finished-dose, packaging, and pharmaceutical-chemical corridor
  • North Carolina research-triangle and sterile or biologic-adjacent manufacturing
  • Illinois and Massachusetts specialty, sterile, and research-adjacent production
  • California clinical, specialty, and West Coast packaging and distribution nodes

Selection rules

  1. Match dosage form first: solid oral, liquid, sterile, topical, or packaging-only. A listed pharmaceutical plant is not automatically qualified for every form.
  2. Confirm FDA registration, license, and the last inspection or quality-system evidence the company will share.
  3. Ask which operations stay on site versus get contracted, including testing, serialization, and packaging.
  4. Require the same batch size, release-test panel, and change-control rules from every shortlisted site.
  5. Separate clinical or development capacity from commercial supply. Those are different operating models.
  6. Use state pages when the program needs on-site audits, controlled-substance proximity, or a regional packaging node.

When to use a finished-dose plant, a packager, or a development site

A pharmaceutical manufacturer can be a commercial plant, a packager, or a development lab. Choose the site type before comparing listed profiles.

When this is the jobUseWhy
Commercial finished-dose supply with batch records and release testingcGMP finished-dose manufacturerThe award depends on registered process, documentation, and inspection history.
Primary or secondary packaging, serialization, or labeling onlyPharmaceutical packagerThe product is already made; the constraint is coding, artwork, and distribution-ready pack-out.
Clinical, scale-up, or formulation development before commercial transferDevelopment or CDMO siteThe buyer needs process development and tech-transfer evidence, not only commercial volume.

How to source this work

Use a pharmaceutical manufacturer when cGMP, FDA registration, dosage form, contamination control, and batch documentation—not general contract manufacturing capacity—are the buying criteria.

Include in the RFQ

  • dosage form, batch size, and commercial or clinical intent
  • required registrations, licenses, and quality-system scope
  • raw-material, packaging-component, and approved-source rules
  • in-process, release, and stability testing requirements
  • serialization, labeling, storage, and change-control expectations

Questions that separate suppliers

  • Is the site registered and inspected for this dosage form?
  • Which operations are performed in-house versus by a qualified contractor?
  • What batch records, COAs, and deviation history will the buyer receive?

Questions this page can answer

How should a buyer compare pharmaceutical manufacturers?

Start with dosage form, registration, and quality-system scope. Then compare which operations are on site, what batch records look like, and whether the site is set up for clinical or commercial supply. Directory listing is not an FDA approval.

Which states should pharmaceutical buyers check first?

New Jersey, Pennsylvania, North Carolina, Massachusetts, and California are the first UNITEMFG state-and-category pages to open. Use California for specialty, clinical, and West Coast packaging work; keep the Mid-Atlantic pages for finished-dose density.

What evidence should appear on a pharmaceutical manufacturer profile?

Look for a current description, dosage-form or specialty language, location, and any recorded registrations or quality claims. Then confirm FDA registration, licenses, and inspection status directly with the company and official sources.

When is a national pharmaceutical search better than a state search?

Search nationally when the program can transfer to any qualified U.S. site and the dosage form is rare. Use a state page when audit travel, controlled logistics, or an existing regional quality network is part of the decision.

Pharmaceuticals manufacturing corridors

Open a corridor page when plant visits, freight, or a regional production cluster change the award. Counts below are complete listed profiles on each state page. 46 states currently have listed pharmaceuticals manufacturer profiles.

Other states with listed plants

How this pharmaceuticals directory should be used

Use it to build a realistic shortlist

Pharmaceuticals awards usually fail when every listed plant is treated as interchangeable. Use the state pages and the selection rules above to separate process fit, regulated-site requirements, and regional clusters before sending outreach.

Directory status is not a plant audit

Listed profiles are a starting point for supplier research. Confirm current capacity, registrations, certifications, and quality evidence directly with the manufacturer.

When to stay on the national page

Stay here when the process itself is rare or the program can transfer to any qualified U.S. site. Open a state page when freight, audit travel, or a known production corridor is part of the decision.

Why compare U.S. pharmaceuticals manufacturers?

  • Easier site visits, quoting conversations, and quality follow-up
  • Clearer documentation, change-control, and release-test expectations
  • Shorter freight paths for regulated, refrigerated, or hazardous shipments
  • More practical communication when requirements change mid-program

Compare listed pharmaceuticals plants

Open the full directory when you have process, batch size, and documentation requirements. Use a state page when freight or a plant visit is part of the award.